当前位置: 首页 > 期刊 > 《医学与护理》 > 2009年第5期
编号:11793931
Tokk样受体信号通路的研究进展(3)
http://www.100md.com 2009年5月1日 《医学与护理》 2009年第5期
     [15] Burna K,Janssens S,Brissoni B,etal.Inhibition 0f interleukin 1 receptor/To11 like receptor signaling through altermatively spliced ,short form of MyD88s is due to its falure to recruit IRAK4﹝J﹞.JEM,2003,197(2):263~268.

    [16]Rao N,Nguyen S,Ngo K,etal.A novel splice variant of interleukin-1/receptor(IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induce inflammatory signaling﹝J﹞.MCB,2005, 25(15):6521~6532.

    [17] Takeda K,Akira S.TLR signaling pathways[J].seminars in immunology, 2004,16: 3~9

    [18] Takeshita F,Ishii KJ,Kobiyama K,et al.TRAF4acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF[J].EUR.J.immunol,2005,35(8) :2477~2485.

    [19] Zhang GL,Ghoah S.Negative regulation of Toll-like receptor-mediated signaling by Tollip[J].J.Biol.Chem,2002,277(9) :7059~7065.

    [20] Negishi H,Ohba Y,Yanai H,et al.Negative regulation of Toll-like-receptor signaling IRF-4﹝J﹞.PNAS,2005,102(44):15989~15994.

    [21]王德成、佘敏、佘锐萍等.Toll样受体研究进展[J].动物医学进展,2008,29(2):56-60.

    作者简介:

    赵晓艳女(1982-),籍贯:河北省承德市宽城县,满族,研究生。, http://www.100md.com
上一页1 2 3